Browsing Category

Top Industry News

7087 posts

Fujifilm Diosynth Biotechnologies Investing $1.2 Bn More In Biomanufacturing Expansion
By

By
Fujifilm Corporation, the parent company of Fujifilm Diosynth Biotechnologies, has announced an additional investment of $1.2 billion to further expand Fujifilm’s Diosynth Biotechnologies biomanufacturing facility in Holly Springs, North Carolina,…

Moderna Pauses Plan for $500-M mRNA Mfg Plant in Kenya 
By

By
Moderna has paused its efforts to build a $500-million mRNA manufacturing facility in Kenya while it determines future demand for mRNA vaccines on the African continent. Moderna announced the plans…

White House Releases Strategy to Strengthen Global Health Security
By

By
The White House launched this week (April 16, 2024), the US Global Health Security Strategy, a five-year plan designed as a  whole-of-government, science-based approach to strengthening global health security.   The…

Supplier News: Asahi Kasei, TriLink & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Axplora, Asahi Kasei Bioprocess, Axolabs, TriLink BioTechnologies, API Innovation Center, Apertus, 89bio, BiBo Biopharma Engineering, Kincell Bio and Imugene.   Chemicals/Chemical API Manufacturing *…

Partnering News: AbbVie, CureVac & More 
By

By
A roundup of bio/pharmaceutical partnering news from AbbVie/Medincell and CureVac/MD Anderson Cancer Center.  * AbbVie, Medincell in $1.9-Bn Injectables Pact* CureVac, MD Anderson Cancer Center in Cancer Vaccine Pact AbbVie,…

Vertex To Acquire Alpine Immune Sciences for $4.9 Bn 
By

By
Vertex Pharmaceuticals, a Boston-based bio/pharmaceutical company, has agreed to acquire Alpine Immune Sciences, a Seattle, Washington-based clinical-stage bio/pharmaceutical company developing protein-based immunotherapies, for approximately $4.9 billion.  Alpine’s lead molecule, povetacicept…

Blackstone Providing $750 M To Fund Moderna’s Influenza Program 
By

By
Moderna, a Cambridge, Massachusetts-based bio/pharmaceutical company, and Blackstone, an investment-management firm, have announced a new collaboration under which Blackstone will provide up to $750 million to fund Moderna’s influenza program. …

Supplier News: Euroapi, MilliporeSigma, Schott & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Euroapi, MilliporeSigma, Schott Pharma, CoreRx and AustinPx.   Chemicals/Chemical API Manufacturing * Euroapi Reorganizes Executive Leadership Biologics Manufacturing * MilliporeSigma Investing $326 M in Biologic Mfg…

Partnering News: Gilead, Merck KGaA, Novartis & Teva  
By

By
A roundup of bio/pharmaceutical partnering news from Gilead Sciences/Nurix Therapeutics, Merck KGaA/Caris Discovery, Novartis/Arvinas and Teva/mAbXience.  * Gilead, Nurix Therapeutics Extend $1.8-Bn Research Pact* Merck KGaA, Caris in $1.4-Bn ADC…

Mfg News: Novartis & Novo Nordisk 
By

By
A roundup of manufacturing news from Novartis and Novo Nordisk/Ginkgo. Highlights below.  * Novartis To Implement Mfg Changes for Breast Cancer Drug Candidate due to Nitrosamine Impurities * Novo Nordisk, Ginkgo…